Frazier Life Sciences Acquisition Corp. II (the “Company”), a special purpose acquisition company, announced today the ...
Conexeu Sciences Inc. (Nasdaq: CNXU) (“Conexeu” or the “Company”), a preclinical-stage medical device and regenerative ...
(NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business ...
(Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for ...
(Nasdaq: EXEL) announced today that its third quarter 2026 financial results will be released on Thursday, October 29, 2026, ...
(Nasdaq: CDNA) – a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today ...
New mechanistic research and clinician-reported real-world experience adds to the evolving evidence base for birch ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the Stealth AXiS™ surgical system ...
Battelle Extends Longstanding CDC Partnership with New Public Health Data and Mission Support Awards
Battelle today announced two significant awards from the Centers for Disease Control and Prevention (CDC), reinforcing the ...
Seven studies spanning middle molecule clearance, home dialysis and patient experience highlight DaVita's commitment to ...
(NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for ...
STAR, a structured training and certification program for clinical trial imaging professionals. LONDON, ON and BERLIN, Oct.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results